Loss-of-function of the hippo transducer TAZ reduces mammary tumor growth through a myeloid-derived suppressor cell-dependent mechanism
Cancer Gene Therapy, Published online: 15 July 2022; doi:10.1038/s41417-022-00502-0Loss-of-function of the hippo transducer TAZ reduces mammary tumor growth through a myeloid-derived suppressor cell-dependent mechanism (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 15, 2022 Category: Cancer & Oncology Authors: He Shen Yuwen Zhang Elliot D. Kramer Eriko Katsuta Yin Wan Yanmin Chen Jianmin Wang Yali Zhang Junko Matsuzaki Costa Frangou Scott I. Abrams Jianmin Zhang Source Type: research

MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state
Cancer Gene Therapy, Published online: 15 July 2022; doi:10.1038/s41417-022-00504-yMicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 15, 2022 Category: Cancer & Oncology Authors: Wen Cai Zhang Nicholas Skiados Fareesa Aftab Cerena Moreno Luis Silva Paul Joshua Anthony Corbilla John M. Asara Aaron N. Hata Frank J. Slack Source Type: research

Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
Cancer Gene Therapy, Published online: 15 July 2022; doi:10.1038/s41417-022-00501-1Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4 (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 15, 2022 Category: Cancer & Oncology Authors: Tianzhen Hu Chengyun Pan Tianzhuo Zhang Ming Ni Weili Wang Siyu Zhang Ying Chen Jishi Wang Qin Fang Source Type: research

Cancer vaccine strategies using self-replicating RNA viral platforms
Cancer Gene Therapy, Published online: 12 July 2022; doi:10.1038/s41417-022-00499-6Cancer vaccine strategies using self-replicating RNA viral platforms (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 12, 2022 Category: Cancer & Oncology Authors: Gabrielle P. Dailey Erika J. Crosby Zachary C. Hartman Source Type: research

Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma
Cancer Gene Therapy, Published online: 11 July 2022; doi:10.1038/s41417-022-00489-8Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 11, 2022 Category: Cancer & Oncology Authors: Ming-Chuang Zhu Yan-Hong Zhang Peng Xiong Xiao-Wu Fan Guo-Liang Li Min Zhu Source Type: research

Application of ATAC-seq in tumor-specific T cell exhaustion
Cancer Gene Therapy, Published online: 06 July 2022; doi:10.1038/s41417-022-00495-wApplication of ATAC-seq in tumor-specific T cell exhaustion (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 6, 2022 Category: Cancer & Oncology Authors: Chufeng Chen Jiaying Liu Yidong Chen Anqi Lin Weiming Mou Lingxuan Zhu Tao Yang Quan Cheng Jian Zhang Peng Luo Source Type: research

Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
Cancer Gene Therapy, Published online: 06 July 2022; doi:10.1038/s41417-022-00491-0Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 6, 2022 Category: Cancer & Oncology Authors: Patricia K. Gr üninger Franziska Uhl Heike Herzog Gaia Gentile Marta Andrade-Martinez Tobias Schmidt Kyuho Han David W. Morgens Michael C. Bassik Michael L. Cleary Oliver Gorka Robert Zeiser Olaf Gro ß Jes ús Duque-Afonso Source Type: research

LncRNAs in breast cancer: a link to future approaches
Cancer Gene Therapy, Published online: 04 July 2022; doi:10.1038/s41417-022-00487-wLncRNAs in breast cancer: a link to future approaches (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 4, 2022 Category: Cancer & Oncology Authors: Nikolaos Sideris Paola Dama Salih Bayraktar Thomas Stiff Leandro Castellano Source Type: research

Correction to: Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis
Cancer Gene Therapy, Published online: 01 July 2022; doi:10.1038/s41417-022-00498-7Correction to: Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 1, 2022 Category: Cancer & Oncology Authors: Jiulong Ma Chen Chen Shan Liu Jiahua Ji Di Wu Peng Huang Dexian Wei Zhimin Fan Liqun Ren Source Type: research

Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cells
Cancer Gene Therapy, Published online: 29 June 2022; doi:10.1038/s41417-022-00497-8Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 29, 2022 Category: Cancer & Oncology Authors: Xiaobin Wang Xiaoyu Liu Huihan Wang Source Type: research

SIX3 function in cancer: progression and comprehensive analysis
Cancer Gene Therapy, Published online: 28 June 2022; doi:10.1038/s41417-022-00488-9SIX3 function in cancer: progression and comprehensive analysis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 28, 2022 Category: Cancer & Oncology Authors: Tian-Liang Ma Peng Zhu Jing-Xian Chen Yi-He Hu Jie Xie Source Type: research

GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway
Cancer Gene Therapy, Published online: 27 June 2022; doi:10.1038/s41417-022-00490-1GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 27, 2022 Category: Cancer & Oncology Authors: Yuen Chak Tiu Lanqi Gong Yu Zhang Jie Luo Yuma Yang Ying Tang Wing-mui Lee Xin-Yuan Guan Source Type: research

CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9
Cancer Gene Therapy, Published online: 27 June 2022; doi:10.1038/s41417-022-00492-zCircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9 (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 27, 2022 Category: Cancer & Oncology Authors: Yuwei Zhang Fengping Liu Yangkun Feng Xinyu Xu Yang Wang Sha Zhu Jian Dong Shanchao Zhao Bin Xu Ninghan Feng Source Type: research

Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells
Cancer Gene Therapy, Published online: 24 June 2022; doi:10.1038/s41417-022-00493-yStabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 24, 2022 Category: Cancer & Oncology Authors: Feng Luo Jinbang Li Jihong Liu Kunping Liu Source Type: research

Molecular crosstalk between CUEDC2 and ERα influences the clinical outcome by regulating mitosis in breast cancer
Cancer Gene Therapy, Published online: 22 June 2022; doi:10.1038/s41417-022-00494-xMolecular crosstalk between CUEDC2 and ERα influences the clinical outcome by regulating mitosis in breast cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - June 22, 2022 Category: Cancer & Oncology Authors: Stuti Roy Suryendu Saha Debanil Dhar Puja Chakraborty Kumar Singha Roy Chitranjan Mukherjee Arnab Gupta Samir Bhattacharyya Anup Roy Sanghamitra Sengupta Susanta Roychoudhury Somsubhra Nath Source Type: research